دورية أكاديمية

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer ; An Analysis of Data From the I-SPY2 Randomized Clinical Trial

التفاصيل البيبلوغرافية
العنوان: Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer ; An Analysis of Data From the I-SPY2 Randomized Clinical Trial
المؤلفون: Symmans, W. Fraser, Yau, Christina, Chen, Yunn-Yi, Balassanian, Ron, Klein, Molly E., Pusztai, Lajos, Nanda, Rita, Parker, Barbara A., Datnow, Brian, Krings, Gregor, Wei, Shi, Feldman, Michael D., Duan, Xiuzhen, Chen, Beiyun, Sattar, Husain, Khazai, Laila, Zeck, Jay C., Sams, Sharon, Mhawech-Fauceglia, Paulette, Rendi, Mara, Sahoo, Sunati, Ocal, Idris Tolgay, Fan, Fang, LeBeau, Lauren Grasso, Vinh, Tuyethoa, Troxell, Megan L., Chien, A. Jo, Wallace, Anne M., Forero-Torres, Andres, Ellis, Erin, Albain, Kathy S., Murthy, Rashmi K., Boughey, Judy C., Liu, Minetta C., Haley, Barbara B., Elias, Anthony D., Clark, Amy S., Kemmer, Kathleen, Isaacs, Claudine, Lang, Julie E., Han, Hyo S., Edmiston, Kirsten, Viscusi, Rebecca K., Northfelt, Donald W., Khan, Qamar J., Leyland-Jones, Brian, Venters, Sara J., Shad, Sonal, Matthews, Jeffrey B., Asare, Smita M.
المصدر: JAMA Oncology ; volume 7, issue 11, page 1654 ; ISSN 2374-2437
بيانات النشر: American Medical Association (AMA)
سنة النشر: 2021
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1001/jamaoncol.2021.3690
الإتاحة: https://doi.org/10.1001/jamaoncol.2021.3690Test
https://jamanetwork.com/journals/jamaoncology/articlepdf/2783768/jamaoncology_symmans_2021_oi_210056_1636656364.02509.pdfTest
رقم الانضمام: edsbas.70C942A3
قاعدة البيانات: BASE